microdosing glp 1 athletes GLP-1 Use in Athletes: Safety & Performance Considerations – PlexusDx GLP-1 Microdosing 2026: 0.1mg Chart

Another open-label, randomized phase III inferiority study looked at mean A1c reduction in type 2 diabetics not controlled on metformin when treated with semaglutide or tirzepatide and tirzepatide was again found non-inferior (and even superior) in reducing A1c

What is the Microdose GLP-1 Protocol, and who should use it

Note: Taking D-Carnitine can cause interference with the supplementation of L-Carnitine, which can then cause further problems

Limitations : As a case report with one patient (N=1 study), the findings are anecdotal and require corroboration through larger, controlled studies to establish broader applicability

Unmonitored Side Effects: Without clinical supervision, users face a high risk of severe side effects like acute pancreatitis, kidney injury, bowel obstruction, and potential thyroid tumors Prescription Violations: These are Schedule-H drugs that must be prescribed only by specialists like endocrinologists